Shareholder Analysis

Significant Shareholdings

As at 8 January 2020, the Company’s issued share capital consists of 214,750,501 ordinary shares with a nominal value of 5p each (“Ordinary Shares”), each share having equal voting rights.

As at 8 January 2020 the Company’s major shareholders are:

Table: “Significant shareholdings”

 

ShareholdersPercentage of shares held
Octopus Investments Limited10.52%
AXA SA7.21%
Canaccord Genuity Group Inc7.20%
Blackrock Inc4.71%
Investec Group4.62%
Groupama4.26%
Charles Stanley Group3.93%
Aviva plc3.85%
Aegon3.38%

 

In accordance with the AIM Rules (Rule 26), insofar as the Company is aware as at 8 January 2020, the percentage of the Company’s issued share capital that is not in public hands is 2.42%. This percentage consists of the holdings of the directors’ beneficial holdings and the holdings of the AMS Trustee Company in respect of the Company’s Deferred Share Bonus Scheme. The Company’s free float is 97.58%.

Any corporate shareholders who wish to contact AMS, or provide information on their shareholding, can send an email to companysecretary@admedsol.com.